Genetic Markers in Relation to Bevacizumab-induced Hypertension

Diether Lambrechts; D.W. Miles; N Leight; Leonard B. Saltz; B. Escudier; Eric Van Cutsem; Aruna T. Bansal; S.J. Scherer; Peter Carmeliet; Sanne de Haas

Article2011

1412 POSTER Genetic Markers in Relation to Bevacizumab-induced Hypertension

Diether Lambrechts, D.W. Miles, N. B. Leighl, Leonard B. Saltz, Bernard Escudier, Eric Van Cutsem, Abhishek Bansal, S.J. Scherer, Peter Carmeliet, Sanne de Haas

Article2014

Genetic markers of bevacizumab-induced hypertension

Diether Lambrechts, Matthieu Moisse, Paul Delmar, David W. Miles, Natasha B. Leighl, Bernard Escudier, Eric Van Cutsem, Aruna T. Bansal, Peter Carmeliet, Stefan Scherer, Sanne de Haas, Céline Pallaud

Article2017

Genetic Interactions with Age, Sex, Body Mass Index, and Hypertension in Relation to Atrial Fibrillation: The AFGen Consortium

Lu‐Chen Weng, Kathryn L. Lunetta, Martina Müller‐Nurasyid, Albert V. Smith, Sébastien Thériault, Peter Weeke, John Barnard, Joshua C. Bis, Leo‐Pekka Lyytikäinen, Marcus E. Kleber, Andreas Martinsson, Henry J. Lin, Michiel Rienstra, Stella Trompet, Bouwe P. Krijthe, Marcus Dörr, Derek Klarin, Daniel I. Chasman, Moritz F. Sinner, Mélanie Waldenberger, Lenore J. Launer, Tamara B. Harris, Elsayed Z. Soliman,

Article2003

Inflammation markers in relation to cognition in a healthy aging population

Charlotte E. Teunissen, Martin P.J. van Boxtel, Hans Bosma, E. Bosmans, Joris R. Delanghe, C. De Bruijn, Annick Wauters, Michael Maes, J. Jolles, H.W.M. Steinbusch, Jan de Vente

Article2013

Markers of Response for the Antiangiogenic Agent Bevacizumab

Diether Lambrechts, Heinz‐Josef Lenz, Sanne de Haas, Peter Carmeliet, Stefan Scherer

Genetic Markers in Relation to Bevacizumab-induced Hypertension

Discussion(0)

Related publications

1412 POSTER Genetic Markers in Relation to Bevacizumab-induced Hypertension

Genetic markers of bevacizumab-induced hypertension

Genetic Interactions with Age, Sex, Body Mass Index, and Hypertension in Relation to Atrial Fibrillation: The AFGen Consortium

Inflammation markers in relation to cognition in a healthy aging population

Markers of Response for the Antiangiogenic Agent Bevacizumab